Iepsen EW, Lundgren J, Dirksen C, et al
Notably, Epitalon appears to selectively induce apoptosis in cancer cells without harming normal, healthy tissue, indicating its potential as a targeted anti-cancer therapy
so this is one of the most promising therapies
Dissecting the heterogeneity in T-cell mediated inflammation in IBD
Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach